Carlos R Oliveira, MD, PhD
Cards
Contact/Administration
About
Contact/Administration
About
Contact/Administration
Contact Info
Pediatric Infectious Diseases
PO Box 208064
New Haven, CT 06520
United States
Appointments
Titles
Assistant Professor of Pediatrics (Infectious Diseases & Global Health), of Biostatistics (Health Informatics), and of Biomedical Informatics and Data Science
Medical Director, Pediatric AIDS Program
Faculty, Yale Combined Program in the Biological and Biomedical Sciences (BBS)
Contact Info
Pediatric Infectious Diseases
PO Box 208064
New Haven, CT 06520
United States
Appointments
Titles
Assistant Professor of Pediatrics (Infectious Diseases & Global Health), of Biostatistics (Health Informatics), and of Biomedical Informatics and Data Science
Medical Director, Pediatric AIDS Program
Faculty, Yale Combined Program in the Biological and Biomedical Sciences (BBS)
Contact Info
Pediatric Infectious Diseases
PO Box 208064
New Haven, CT 06520
United States
About
Titles
Assistant Professor of Pediatrics (Infectious Diseases & Global Health), of Biostatistics (Health Informatics), and of Biomedical Informatics and Data Science
Medical Director, Pediatric AIDS Program; Faculty, Yale Combined Program in the Biological and Biomedical Sciences (BBS)
Biography
Dr. Carlos Oliveira is an attending physician and specialist in pediatric infectious diseases at Yale New Haven Children's Hospital. He is Board Certified in General Pediatrics, Pediatric Infectious Diseases, and Clinical Informatics and serves on the faculty at both Yale School of Medicine and Yale School of Public Health as an Assistant Professor of Pediatrics (Infectious Diseases & Global Health), of Biostatistics (Health Informatics), and of Biomedical Informatics & Data Science. Dr. Oliveira serves as the Director for Yale’s clinical programs in Pediatric HIV/AIDS, Congenital Infectious Diseases, and Pediatric COVID-19. Dr. Oliveira leads a research group that pursues quantitative, experimental, and field research centered around various aspects of vaccinology and epidemiology of perinatal/neonatal infections.
Appointments
Pediatric Infectious Diseases
Assistant ProfessorPrimaryBiomedical Informatics & Data Science
Assistant ProfessorSecondaryBiostatistics
Assistant ProfessorSecondary
Other Departments & Organizations
- Biomedical Informatics & Data Science
- Biostatistics
- Center for Infection and Immunity
- Computational Biology and Biomedical Informatics
- HPV Working Group (Niccolai Lab)
- Pediatric Immunology Program
- Pediatric Infectious Diseases
- Pediatric Infectious Diseases Consultation Program
- Pediatrics
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Institute for Global Health
- Yale Medicine
- Yale School of Public Health
Education & Training
- PhD
- Yale Graduate School of Arts and Sciences, Investigative Medicine
- Clinical Fellow
- Yale New Haven Children's Hospital (2016)
- Health Services Research Trainee
- Yale University
- Resident
- Children’s Medical Center, University Of Texas Southwestern, Department of Pediatrics
- MD
- University of Texas Southwestern Medical School
- BS
- Dallas Baptist University, Biology
Research
Overview
Public Health Interests
ORCID
0000-0003-1897-6581- View Lab Website
Yale Pediatric Center for Vaccine Research
Research at a Glance
Yale Co-Authors
Publications Timeline
Sangini S. Sheth, MD, MPH, FACOG
Alla Vash-Margita, MD, FACOG
Christine Miller, DO
Linda Niccolai, PhD
Mallory Kathryn Ellingson, MPH
Shefali Pathy, MD, MPH
Publications
2024
Post-Acute sequelae of COVID-19 in pediatric patients within the United States: A Scoping Review
Miller C, Borre C, Green A, Funaro M, Oliveira C, Iwasaki A. Post-Acute sequelae of COVID-19 in pediatric patients within the United States: A Scoping Review. American Journal Of Medicine Open 2024, 100078. DOI: 10.1016/j.ajmo.2024.100078.Peer-Reviewed Original ResearchAltmetricConceptsClinical epidemiologyPost-acute sequelae of COVID-19High risk of biasLack of standardized definitionsPost-acute sequelaeRisk of biasSequelae of COVID-19United StatesScoping reviewComprehensive literature searchUS childrenShort follow-up durationFollow-up durationInclusion criteriaFemale sexOlder ageRisk factorsSARS-CoV-2 infectionLiterature searchChest painHigh riskOptimal preventionPediatric patientsPersistent symptomsCOVID-19Examining Clinical Features and Severe Neurologic Disease of Parechovirus Infection in Young Infants: A Multistate Cohort Study
Evans A, Singh S, Joshi C, Filkins L, Akkoyun E, Custodio H, Daniels E, Kao C, Richardson K, Carrillo-Marquez M, Borré C, Oliveira C, Espinosa C, Mandelia Y, Mazade M, Kimberlin D. Examining Clinical Features and Severe Neurologic Disease of Parechovirus Infection in Young Infants: A Multistate Cohort Study. Clinical Infectious Diseases 2024, ciae400. PMID: 39093815, DOI: 10.1093/cid/ciae400.Peer-Reviewed Original ResearchAltmetricConceptsSevere neurological diseaseLongitudinal follow-up of infantsYoung infantsSevere diseaseViral co-infectionsNon-severe diseaseSpectrum of illnessNeurological diseasesParechovirus infectionLongitudinal follow-upPreterm gestationHPeV infectionClinical seizuresClinical featuresPoor feedingCerebral edemaHuman parechovirusCohort studyU.S. infantsCo-infectionHPeVRespiratory symptomsInfantsSevere casesDiseaseReduction in Unindicated Cervical Cancer Screening in Adolescents in a Large Health Care System.
Geng B, Oliveira C, Hosier H, Sheth S, Vash-Margita A. Reduction in Unindicated Cervical Cancer Screening in Adolescents in a Large Health Care System. Journal Of Lower Genital Tract Disease 2024 PMID: 39037856, DOI: 10.1097/lgt.0000000000000831.Peer-Reviewed Original ResearchConceptsBest Practice AdvisoryCervical cancer screeningElectronic medical recordsHealth care systemCancer screeningPap testCare systemLarger health care systemPre/post intervention studyEvidence-based guidelinesProvider notificationPostinterventionPractice advisoryIntervention studiesPreinterventionFisher's exact testHuman papillomavirus test resultsLogistic regressionRetrospective chart reviewReproductive healthMedical recordsHuman papillomavirus testingPatient characteristicsChart reviewKruskal-Wallis testRisk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis
Aparicio C, Willis Z, Nakamura M, Wolf J, Little C, Maron G, Sue P, Anosike B, Miller C, Bio L, Singh P, James S, Oliveira C. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis. Journal Of The Pediatric Infectious Diseases Society 2024, 13: 352-362. PMID: 38780125, PMCID: PMC11519042, DOI: 10.1093/jpids/piae052.Peer-Reviewed Original ResearchCitationsAltmetricConceptsOdds ratioCritical COVID-19Absolute riskMeta-analysisSystematic reviewRisk stratificationConfidence intervalsInvasive mechanical ventilation requirementRisk factorsEstimate pooled odds ratiosSignificant ORsKey risk factorsPooled odds ratioCritical diseaseIntensive care unit admissionStatistically significant ORsMechanical ventilation requirementRandom-effects modelRisk of critical diseaseChronic pulmonary conditionsHealth conditionsIndependent reviewersPooled ORInclusion criteriaCOVID-19Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design
Gross R, Thaweethai T, Rosenzweig E, Chan J, Chibnik L, Cicek M, Elliott A, Flaherman V, Foulkes A, Witvliet M, Gallagher R, Gennaro M, Jernigan T, Karlson E, Katz S, Kinser P, Kleinman L, Lamendola-Essel M, Milner J, Mohandas S, Mudumbi P, Newburger J, Rhee K, Salisbury A, Snowden J, Stein C, Stockwell M, Tantisira K, Thomason M, Truong D, Warburton D, Wood J, Ahmed S, Akerlundh A, Alshawabkeh A, Anderson B, Aschner J, Atz A, Aupperle R, Baker F, Balaraman V, Banerjee D, Barch D, Baskin-Sommers A, Bhuiyan, Bind M, Bogie A, Bradford T, Buchbinder N, Bueler E, Bükülmez H, Casey B, Chang L, Chrisant M, Clark D, Clifton R, Clouser K, Cottrell L, Cowan K, D’Sa V, Dapretto M, Dasgupta S, Dehority W, Dionne A, Dummer K, Elias M, Esquenazi-Karonika S, Evans D, Faustino E, Fiks A, Forsha D, Foxe J, Friedman N, Fry G, Gaur S, Gee D, Gray K, Handler S, Harahsheh A, Hasbani K, Heath A, Hebson C, Heitzeg M, Hester C, Hill S, Hobart-Porter L, Hong T, Horowitz C, Hsia D, Huentelman M, Hummel K, Irby K, Jacobus J, Jacoby V, Jone P, Kaelber D, Kasmarcak T, Kluko M, Kosut J, Laird A, Landeo-Gutierrez J, Lang S, Larson C, Lim P, Lisdahl K, McCrindle B, McCulloh R, McHugh K, Mendelsohn A, Metz T, Miller J, Mitchell E, Morgan L, Müller-Oehring E, Nahin E, Neale M, Ness-Cochinwala M, Nolan S, Oliveira C, Osakwe O, Oster M, Payne R, Portman M, Raissy H, Randall I, Rao S, Reeder H, Rosas J, Russell M, Sabati A, Sanil Y, Sato A, Schechter M, Selvarangan R, Tejtel S, Shakti D, Sharma K, Squeglia L, Srivastava S, Stevenson M, Szmuszkovicz J, Talavera-Barber M, Teufel R, Thacker D, Trachtenberg F, Udosen M, Warner M, Watson S, Werzberger A, Weyer J, Wood M, Yin H, Zempsky W, Zimmerman E, Dreyer B, Consortium O. Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design. PLOS ONE 2024, 19: e0285635. PMID: 38713673, PMCID: PMC11075869, DOI: 10.1371/journal.pone.0285635.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsYoung adultsClinical courseAdolescent Brain Cognitive DevelopmentCaregiver-child pairsLong-term outcomesObservational cohort studyOutcomes of COVID-19De novo cohortAdolescent Brain Cognitive Development StudySociodemographic correlatesCommunity partnersBaseline assessmentLongitudinal follow-upPotential therapeutic interventionsPediatric protocolsCohort studyCollaborative partnershipsProspective cohortFollow-upStudy protocolFederal partnersNIH Researching COVIDLong-term outcomes of COVID-19Enhanced recoveryData collectionCore outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study “PC-COS Children”
Seylanova N, Chernyavskaya A, Degtyareva N, Mursalova A, Ajam A, Xiao L, Aktulaeva K, Roshchin P, Bobkova P, Aiyegbusi O, Anbu A, Apfelbacher C, Asadi-Pooya A, Ashkenazi-Hoffnung L, Brackel C, Buonsenso D, de Groote W, Diaz J, Dona D, Galvin A, Genuneit J, Goss H, Hughes S, Jones C, Kuppalli K, Malone L, McFarland S, Needham D, Nekliudov N, Nicholson T, Oliveira C, Schiess N, Segal T, Sigfrid L, Thorne C, Vijverberg S, Warner J, Were W, Williamson P, Munblit D, Group T, Kassim A, Chevinsky J, Choong K, Duncan R, Esposito S, Foster R, Guekht A, Jaure A, Mackenzie C, Matthies-Bonn V, Matvienko-Sikar K, McCloud L, McParland D, Miron V, Murthy S, Connel S, O’Hara M, Ogonowska-Slodownik A, Pavare J, Robertson P, Rossman J, Săndulescu O, Saydah S, Schmitt J, Semple M, Shafran R, Snipaitiene A, Søraas A, Stephenson T, Tulen L, Galaz G, Vickers D, Vilser D, Waak M, Wells J, Whittaker E, Winer M, Asmanov A, Comberiati P. Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study “PC-COS Children”. European Respiratory Journal 2024, 63: 2301761. PMID: 38359962, PMCID: PMC10938351, DOI: 10.1183/13993003.01761-2023.Peer-Reviewed Original ResearchCitationsAltmetricConceptsCore Outcome Measurement SetCore outcome setPost-COVID-19 conditionHealth outcomesConsensus studyDelphi processConsensus workshopConsensus processConsensus meetingPost-exertional symptomsRelevant health outcomesPhase 1Delphi consensus studyOutcome measurement instrumentsModified Delphi processDelphi consensus processInternational Delphi consensus studyCognitive Functioning ScaleCategorisation of outcomeMeasurement instrumentsPhase 2Young peoplePhysical functionCOVID-19 conditionsOutcome setGuidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce
Willis Z, Oliveira C, Abzug M, Anosike B, Ardura M, Bio L, Boguniewicz J, Chiotos K, Downes K, Grapentine S, Hersh A, Heston S, Hijano D, Huskins W, James S, Jones S, Lockowitz C, Lloyd E, MacBrayne C, Maron G, McDonough M, Miller C, Morton T, Olivero R, Orscheln R, Schwenk H, Singh P, Soma V, Sue P, Vora S, Nakamura M, Wolf J. Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce. Journal Of The Pediatric Infectious Diseases Society 2024, 13: 159-185. PMID: 38339996, PMCID: PMC11494238, DOI: 10.1093/jpids/piad116.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRisk factorsRisk stratificationPediatric intensive care medicineEffects of therapyNon-hospitalized childrenPediatric infectious diseasesSevere COVID-19Cases of infectionMeta-analysis of dataIntensive care medicineClinical characteristicsPreventive therapyPediatric populationManagement of COVID-19Fatal infectionConsensus statementSevere illnessTherapyMeta-analysisTherapeutic interventionsSARS-CoV-2Expert consensusCare medicineRe-convenedGuidance statementsInternational Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward
Brackel C, Noij L, Vijverberg S, Legghe C, Maitland-van der Zee A, van Goudoever J, Buonsenso D, Munblit D, Sigfrid L, McFarland S, Anmyr L, Ashkenazi-Hoffnung L, Bellinat A, Dias N, Edwards A, Fashina T, Juraški R, Gonçalves A, Hansted E, Herczeg V, Hertting O, Jankauskaite L, Kaswandani N, Kevalas R, Krivácsy P, Lorenz M, Malone L, McVoy M, Miller D, Morrow A, Nugawela M, Oliveira C, Oliveira P, Osmanov I, Overmars I, Paintsil E, Pinto Pereira S, Prawira Y, Putri N, Ramos R, Rasche M, Ryd-Rinder M, De Rose C, Samitova E, Jovanović T, Say D, Scott J, Shachar-Lavie I, Shafran R, Shmueli E, Snipaitiene A, Stephenson T, Ténai N, Tosif S, Turkalj M, Valentini P, Vasconcelos L, Villard L, Vilser D, Hashimoto S, Terheggen-Lagro S. International Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward. Pediatric Research 2024, 96: 319-324. PMID: 38287106, DOI: 10.1038/s41390-023-03015-0.Peer-Reviewed Original ResearchCitationsAltmetricConceptsCare programPost-COVID conditionsPhysical therapyPsychological supportIn-person visitsDiagnostic testsCare pathwaysLack of standardized careFramework of prioritiesGuideline developmentStandard careIn-personMultidisciplinary teamIdentified prioritiesDaily lifeCareResearch cohortManagement of childrenAggregate dataClinically treated childrenLong-term COVID-19 sequelaePatient characteristicsConcentration difficultiesReal-life managementSpecific diagnostic tests
2023
1747. Clinical Spectrum of a Large Multi-State U.S. Cohort of Parechovirus Infection in Neonates and Young Infants
Evans A, Filkins L, Custodio H, Daniels E, Kao C, Richardson K, Carrillo-Marquez M, Borré C, Oliveira C, Espinosa C, Bocchini J, Mandelia Y, Mazade M, Santos R, Carr S, Selvarangan R, Kimberlin D. 1747. Clinical Spectrum of a Large Multi-State U.S. Cohort of Parechovirus Infection in Neonates and Young Infants. Open Forum Infectious Diseases 2023, 10: ofad500.1578. PMCID: PMC10678563, DOI: 10.1093/ofid/ofad500.1578.Peer-Reviewed Original ResearchConceptsUniversity of Mississippi Medical CenterMulticenter clinical trialHPeV infectionStudy discontinuationClinical trialsYoung infantsMedical CenterIndustry-sponsored clinical trialsSevere HPeV infectionsMedian hospitalization durationBody fluid specimensParechovirus infectionMedian ageU.S. outbreakPediatric patientsClinical spectrumHospitalization durationFluid specimensHuman parechovirusIRB approvalReport mortalityViral testingBiochemical markersBirth historyInterim analysisHuman Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019
Sheth S, Johnson N, Sullivan E, Torres A, Oliveira C, Niccolai L. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019. Journal Of Women's Health 2023, 33: 28-32. PMID: 37943625, PMCID: PMC10794823, DOI: 10.1089/jwh.2022.0456.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsMid-adult womenVaccination statusHPV vaccinationHPV vaccineHuman Papillomavirus Vaccination StatusHPV vaccination statusHuman papillomavirus vaccinationAge 26 yearsHealth care providersCross-sectional surveyPapillomavirus vaccinationUnvaccinated womenVaccinated womenVaccine informationCare providersVaccinationAdult womenVaccineWomenBehavioral correlatesCorrelatesStatusPotential benefitsYearsParticipants
Academic Achievements & Community Involvement
activity Pediatric COVID-19 Task Force
CommitteesChairDetails03/01/2020 - Presentactivity Eastern Society of Pediatric Research (ESPR)
Professional OrganizationsCouncil MemberDetails02/01/2021 - Presentactivity Pediatric Infectious Diseases Society (PIDS), Committee on Pediatric COVID-19 Therapies
Professional OrganizationsCo-ChairDetails2022 - Presentactivity American Academy of Pediatrics (AAP): Section on Epidemiology, Public Health & Evidence (SOEPHE)
Professional OrganizationsExecutive Committee MemberDetails2022 - Presentactivity American Academy of Pediatrics (AAP): Section on Infectious Diseases (SOID)
Professional OrganizationsMemberDetails2022 - Present
Teaching & Mentoring
Mentoring
Camila Aparicio, MD
Postgrad associate2023 - Present
Clinical Care
Overview
Carlos R. Oliveira, MD, PhD, is a pediatric infectious diseases specialist with expertise in the treatment of viral infections.
Dr. Oliveira is the director of Congenital Infectious Diseases at Yale New Haven Children’s Hospital and is part of the leadership of the pediatric HIV/AIDS and COVID-19 programs.
“I have a special interest in the diagnosis and treatment of perinatal infections, including infections acquired before birth, during the delivery process, and in early infancy,” Dr. Oliveira says. “I also have expertise in the evaluation and management of COVID-19 and its long-term complications in children.”
Dr. Oliveira is also the co-leader of the Yale Network for Vaccine Initiatives, which is committed to improving population health through research and service activities that promote vaccination.
His research focuses on vaccine epidemiology, including post-licensure effectiveness and population level-impact, with the goal of developing and implementing strategies to improve vaccine research and decrease the burden of vaccine-related diseases.
Clinical Specialties
Fact Sheets
Croup
Learn More on Yale MedicineHuman Immunodeficiency Virus (HIV)
Learn More on Yale MedicineCoronavirus
Learn More on Yale MedicineMeningitis
Learn More on Yale Medicine
Board Certifications
Clinical Informatics
- Certification Organization
- AB of Preventive Medicine
- Original Certification Date
- 2022
Pediatric Infectious Disease
- Certification Organization
- AB of Pediatrics
- Original Certification Date
- 2017
Pediatrics
- Certification Organization
- AB of Pediatrics
- Original Certification Date
- 2013
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews & Links
Media
News
- May 02, 2024
56 Yale Pediatricians Recognized by Connecticut Magazine's 2024 “Top Doctors” List
- April 01, 2024
Yale Research Team Awarded $4 Million Grant to Evaluate New Immunizations for Infant RSV
- February 28, 2024
Find Yale Pediatrics at the 2024 Pediatric Academic Societies (PAS) Meeting
- May 05, 2023Source: Stat News
What explains rare heart condition among young men after Covid vaccines? A new study offers clues
Related Links
- Just the facts
- NBA Cares, Vaccines for Teens Event
- New management approaches urged for children with medically unexplained symptoms
- NIH Award
- Opportunities to vaccinate young women against HPV missed at alarming rate
- Pediatric Center for Vaccine Research
- The American Cancer Society’s Mission: HPV Cancer Free campaign
Get In Touch
Contacts
Pediatric Infectious Diseases
PO Box 208064
New Haven, CT 06520
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.